Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2026-05-20 @ 10:29 AM
Study NCT ID:
NCT06823960
Status:
RECRUITING
Last Update Posted:
2025-02-12
First Post:
2025-02-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)
Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ZanOs
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None